What does CUSIP 918385105 represent in this 13F holders report?

CUSIP 918385105 is the security identifier for VTVT - VTV THERAPEUTICS INC - CL A used to aggregate holder disclosures.

How many institutions held VTVT - VTV THERAPEUTICS INC - CL A in Q2 2018?

25 institutional investors reported VTVT - VTV THERAPEUTICS INC - CL A for Q2 2018. Use the holders table for investor-level position and value details.

VTV THERAPEUTICS INC - CL A (VTVT)

CUSIP: 918385105

Q2 2018 13F Holders as of 30 Jun 2018

Security type / class: Equity / CL A
Total 13F shares: 789,466
Total 13F value: $1,211,961
Share change: -4,124,992
SEC-reported price per share: $1.54
Number of holders: 25
Value change: -$15,974,689
Number of buys: 14
Number of sells: 29

Security key

918385105

Report period

Q2 2018

Institutions

Top holders

VTVT full security history Ownership snapshot Full 13F holder table vTv Therapeutics Inc. SEC filings vTv Therapeutics Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of VTVT - VTV THERAPEUTICS INC - CL A (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

GMT CAPITAL CORP

Disclosed value leader

GMT CAPITAL CORP

Comparable rows

0/15

Latest evidence

31 Mar 2018

13F Highest disclosed value: $3,822,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

GMT CAPITAL CORP has the largest disclosed position value at $3.82M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens GMT CAPITAL CORP's linked filing trail.

Disclosed position value Top 5

GMT CAPITAL CORP $3.82M

FRANKLIN TEMPLETON INC $3.4M

MASSACHUSETTS FINANCIAL SERVICES ... $1.85M

ROYCE & ASSOCIATES LP $1.48M

BlackRock Finance, Inc. $1.39M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
GMT CAPITAL CORP	13F Company 13F	— denominator unverified	$3,822,000 939,100 shares	—	31 Mar 2018
FRANKLIN TEMPLETON INC	13F Company 13F	— denominator unverified	$3,400,000 835,323 shares	—	31 Mar 2018
MASSACHUSETTS FINANCIAL SERVICES CO /MA/	13F Company 13F	— denominator unverified	$1,854,000 455,553 shares	—	31 Mar 2018
ROYCE & ASSOCIATES LP	13F Company 13F	— denominator unverified	$1,477,000 363,000 shares	—	31 Mar 2018
BlackRock Finance, Inc.	13F Company 13F	— denominator unverified	$1,392,000 341,986 shares	—	31 Mar 2018
JPMORGAN CHASE & CO	13F Company 13F	— denominator unverified	$1,333,000 327,728 shares	—	31 Mar 2018

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2018

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

789,466

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2018 vs Q1 2018 Across Filers

Q1 2018 holders

Q2 2018 holders

Holder diff

-13

Investor	Q1 2018 Shares	Q2 2018 Shares	Share Diff	Share Chg %	Q1 2018 value	Q2 2018 value	Value change	Value Chg %